Last SFr.16.83 CHF
Change Today +0.08 / 0.48%
Volume 646.9K
CLN On Other Exchanges
Symbol
Exchange
OTC US
OTC US
SIX Swiss Ex
Frankfurt
As of 11:43 AM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

clariant ag-reg (CLN) Snapshot

Open
SFr.16.74
Previous Close
SFr.16.75
Day High
SFr.16.86
Day Low
SFr.16.71
52 Week High
06/6/14 - SFr.18.80
52 Week Low
10/16/14 - SFr.14.55
Market Cap
5.6B
Average Volume 10 Days
1.6M
EPS TTM
SFr.0.57
Shares Outstanding
331.9M
EX-Date
03/28/14
P/E TM
29.5x
Dividend
SFr.0.36
Dividend Yield
2.14%
Current Stock Chart for CLARIANT AG-REG (CLN)

Related News

No related news articles were found.

clariant ag-reg (CLN) Related Businessweek News

View More BusinessWeek News

clariant ag-reg (CLN) Details

Clariant AG, together with its subsidiaries, develops, manufactures, distributes, and sells a range of specialty chemicals worldwide. It operates in four segments: Care Chemicals, Catalysis & Energy, Natural Resources, and Plastics & Coatings. The Care Chemicals segment offers personal care products, such as preservatives, active ingredients and delivery systems, surfactants and pearlizers, emollients, polymers, hair conditioning agents, and emulsifiers; industrial care products, including specialty chemicals and ethylene oxide derivatives for a range of industries; home care products comprising products for cloth, floor, and dish washing and cleaning; crop protection additives; and enzymes and industrial biotechnology products. The Catalysis & Energy segment provides catalysts for use in the manufacture of ammonia, methanol, hydrogen, synthetic natural gas, petrochemicals and plastics, chemicals and specialties, air and gas purification, and performance materials; and fuels processing, as well as develops materials for rechargeable batteries, and enzymes and industrial biotechnology products. The Natural Resources segment offers various oilfield and mining products based on surfactant technology, which is used to treat oil, gas, or mineral ores; and allow for separation from undesirable components, such as water, sand, impurities, etc. The Plastics & Coatings segment provides additives for functional effects in plastics, coatings, and printing inks; organic pigments, pigment preparations, and dyes used in coatings, printing, plastics, consumer products, and other special applications; and color and additive concentrates, and performance solutions for plastics. Clariant AG was founded in 1886 and is based in Muttenz, Switzerland.

16,936 Employees
Last Reported Date: 10/30/14
Founded in 1886

clariant ag-reg (CLN) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: SFr.4.1M
Compensation as of Fiscal Year 2013.

clariant ag-reg (CLN) Key Developments

Clariant AG Announces Earnings Results for Third Quarter and Nine Months of 2014; Provides Earnings Guidance for the Full Year of 2014

Clariant AG announced earnings results for third quarter and nine months of 2014. For the quarter, the company reported sales of CHF 1,507 million, EBITDA before exceptional items of CHF 211 million, EBIT before exceptional items of CHF 141 million, EBIT of CHF 122 million, net income of CHF 59 million, operating cash flow of CHF 126 million compared to the sales of CHF 1,443 million, EBITDA before exceptional items of CHF 203 million, EBIT before exceptional items of CHF 132 million, EBIT of CHF 147 million, net loss of CHF 204 million, operating cash flow of CHF 153 million for the same quarter a year ago. For the year to date, the company reported sales of CHF 4,530 million, EBITDA before exceptional items of CHF 635 million, EBIT before exceptional items of CHF 426 million, EBIT of CHF 291 million, net income of CHF 85 million, operating cash flow of CHF 13 million compared to the sales of CHF 4,513 million, EBITDA before exceptional items of CHF 623 million, EBIT before exceptional items of CHF 417 million, EBIT of CHF 377 million, net loss of CHF 75 million, operating cash flow of CHF 40 million for the same period a year ago. Net debt stood at CHF 1.608 billion and was therefore higher than the CHF 1.500 billion recorded at year-end 2013. For the full-year 2014, the company expects around mid single-digit sales growth in local currencies and an EBITDA margin before exceptional items above full-year 2013. The company is confident to achieve a net debt of around CHF 1.3 billion by year end 2014.

Evonik Reportedly Eyes DSM

Evonik Industries AG (DB:EVK) intends to acquire Koninklijke DSM N.V. (ENXTAM:DSM), Bloomberg reported, citing sources in the know. Evonik is holding talks with the advisors regarding a potential deal with DSM which would create a company with €22 billion in annual revenue. Other takeover options are also under consideration, the sources said. Evonik would be buying the whole company, however, is mainly interested in the Nutrition unit. As per the insiders, a partial acquisition of DSM is also possible or the takeover of the whole firm, after which certain units will be sold. Evonik has not yet decided to make a new takeover attempt, the sources said. Based on DSM's shareholder structure, an acquisition requires the support of the group's Board of Directors. Evonik, in addition to DSM, is also eyeing Croda International plc (LSE:CRDA) and Clariant AG (SWX:CLN). SeeNews added that spokesperson for Evonik denied plans to buy DSM and said there were not any talks ongoing while DSM declined to comment when contacted by the news agency.

Clariant AG Presents at World Bio Markets USA, Oct-28-2014 05:00 PM

Clariant AG Presents at World Bio Markets USA, Oct-28-2014 05:00 PM. Venue: San Diego Marriott Mission Valley, 8757 Rio San Diego Drive, San Diego, California, United States. Speakers: Martin Mitchell, Global Business Development Manager.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLN:VX SFr.16.83 CHF +0.08

CLN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arkema SA €55.72 EUR +0.97
K+S AG €23.29 EUR +0.035
Lonza Group AG SFr.111.90 CHF +0.80
Nutreco NV €44.23 EUR +0.025
Wacker Chemie AG €91.71 EUR -0.022
View Industry Companies
 

Industry Analysis

CLN

Industry Average

Valuation CLN Industry Range
Price/Earnings 29.1x
Price/Sales 0.8x
Price/Book 1.9x
Price/Cash Flow 36.0x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CLARIANT AG-REG, please visit www.clariant.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.